Cardiac tumors primary prevention: Difference between revisions
Jump to navigation
Jump to search
No edit summary |
No edit summary |
||
| Line 12: | Line 12: | ||
* There are no effective strategies for the primary prevention of cardiac tumors. | * There are no effective strategies for the primary prevention of cardiac tumors. | ||
*The primary prevention is helpful in to reduce the development of heart problems after initiating [[Anthracyclines]] and radiation exposure for the treatment of cardiac malignancies. Some strategies are: | *The primary prevention is helpful in to reduce the development of heart problems after initiating [[Anthracyclines]] and radiation exposure for the treatment of cardiac malignancies. Some strategies are: | ||
**The use of protons (instead of photons) offers the possibility of preserving the proper dose to the size of the tumor while decreasing the dose administered to neighboring normal tissue. | **The use of protons (instead of photons) offers the possibility of preserving the proper dose to the size of the tumor while decreasing the dose administered to neighboring normal tissue.<ref name="pmid30768157">{{cite journal| author=Chow EJ, Leger KJ, Bhatt NS, Mulrooney DA, Ross CJ, Aggarwal S | display-authors=etal| title=Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment. | journal=Cardiovasc Res | year= 2019 | volume= 115 | issue= 5 | pages= 922-934 | pmid=30768157 | doi=10.1093/cvr/cvz031 | pmc=6452306 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30768157 }} </ref> | ||
**Use of alternate anthracycline preparations, such as liposomal versions. | **Use of alternate anthracycline preparations, such as liposomal versions. | ||
**Lifestyle Changes | **Lifestyle Changes<ref name="pmid30768157">{{cite journal| author=Chow EJ, Leger KJ, Bhatt NS, Mulrooney DA, Ross CJ, Aggarwal S | display-authors=etal| title=Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment. | journal=Cardiovasc Res | year= 2019 | volume= 115 | issue= 5 | pages= 922-934 | pmid=30768157 | doi=10.1093/cvr/cvz031 | pmc=6452306 | url=https://www.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pubmed&tool=sumsearch.org/cite&retmode=ref&cmd=prlinks&id=30768157 }} </ref> | ||
==References== | ==References== | ||
Revision as of 14:37, 14 June 2022
|
Cardiac tumors Microchapters |
|
Diagnosis |
|---|
|
Treatment |
|
Case Studies |
|
Cardiac tumors primary prevention On the Web |
|
American Roentgen Ray Society Images of Cardiac tumors primary prevention |
|
Risk calculators and risk factors for Cardiac tumors primary prevention |
Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: {{Dj}
Overview
Presently, primary prevention of cardiac tumors is not possible due to the lack of suitable techniques.
Primary Prevention
Definition: According to Wonca( World Organization of Family Doctors), Primary prevention involves interventions directed toward a vulnerable demographic or individual. Primary prevention is meant to keep a disease from ever arising. Therefore, its intended target consists of healthy people. [1]
- There are no effective strategies for the primary prevention of cardiac tumors.
- The primary prevention is helpful in to reduce the development of heart problems after initiating Anthracyclines and radiation exposure for the treatment of cardiac malignancies. Some strategies are:
References
- ↑ Martins C, Godycki-Cwirko M, Heleno B, Brodersen J (2018). "Quaternary prevention: reviewing the concept". Eur J Gen Pract. 24 (1): 106–111. doi:10.1080/13814788.2017.1422177. PMC 5795741. PMID 29384397.
- ↑ 2.0 2.1 Chow EJ, Leger KJ, Bhatt NS, Mulrooney DA, Ross CJ, Aggarwal S; et al. (2019). "Paediatric cardio-oncology: epidemiology, screening, prevention, and treatment". Cardiovasc Res. 115 (5): 922–934. doi:10.1093/cvr/cvz031. PMC 6452306. PMID 30768157.